Welcoming Remarks and Keynote Address iconWelcoming Remarks and Keynote Address

Welcoming Remarks and Keynote Address

Feb 8, 2021 3:00pm ‐ Feb 8, 2021 3:50pm
Welcoming Remarks iconWelcoming Remarks

Welcoming Remarks

Feb 8, 2021 3:00pm ‐ Feb 8, 2021 3:10pm
COVID-19: Unprecedented Progress but Still Much to be Done iconCOVID-19: Unprecedented Progress but Still Much to be Done

COVID-19: Unprecedented Progress but Still Much to be Done

Feb 8, 2021 3:10pm ‐ Feb 8, 2021 3:50pm
From Lab to Jab. An Update on AstraZeneca’s Vaccine and Therapeutic Antibody Programs iconFrom Lab to Jab. An Update on AstraZeneca’s Vaccine and Therapeutic Antibody Programs

From Lab to Jab. An Update on AstraZeneca’s Vaccine and Therapeutic Antibody Programs

Feb 8, 2021 3:50pm ‐ Feb 8, 2021 4:15pm
Update on Vaccine and Ab Trials iconUpdate on Vaccine and Ab Trials

Update on Vaccine and Ab Trials

Feb 8, 2021 3:50pm ‐ Feb 8, 2021 4:55pm
Vaccines against SARS-CoV-2: Current Status and Future Directions iconVaccines against SARS-CoV-2: Current Status and Future Directions

Vaccines against SARS-CoV-2: Current Status and Future Directions

Feb 8, 2021 4:15pm ‐ Feb 8, 2021 4:40pm
Q&A Discussion iconQ&A Discussion

Q&A Discussion

Feb 8, 2021 4:40pm ‐ Feb 8, 2021 4:55pm
Coffee Break iconCoffee Break

Coffee Break

Feb 8, 2021 4:55pm ‐ Feb 8, 2021 5:10pm
A Paradigm Shift in Airborne Transmission? iconA Paradigm Shift in Airborne Transmission?

A Paradigm Shift in Airborne Transmission?

Feb 8, 2021 5:10pm ‐ Feb 8, 2021 5:35pm
Current Understanding of the High Infectivity and Transmissibility of SARS-CoV-2 iconCurrent Understanding of the High Infectivity and Transmissibility of SARS-CoV-2

Current Understanding of the High Infectivity and Transmissibility of SARS-CoV-2

Feb 8, 2021 5:10pm ‐ Feb 8, 2021 6:15pm